Benzinga's Top Ratings Upgrades, Downgrades For September 6, 2023 - Cheniere Energy (AMEX:LNG), bluebird bio (NASDAQ:BLUE), Trade Desk (NASDAQ:TTD), Johnson & Johnson (NYSE:JNJ), Freightos (NASDAQ:CRGO), Amgen (NASDAQ:AMGN), UnitedHealth Group (NYSE:UNH), Fair Isaac (NYSE:FICO), Olin (NYSE:OLN), LivaNova (NASDAQ:LIVN), LeMaitre Vascular (NASDAQ:LMAT), PetIQ (NASDAQ:PETQ), Kenvue (NYSE:KVUE), Constellation Brands (NYSE:STZ), Zoetis (NYSE:ZTS), MACOM Technology Solns (NASDAQ:MTSI), CME Gr (NASDAQ:CME), Block (NYSE:SQ), Celanese (NYSE:CE), MP Materials (NYSE:MP), Federal Agricultural (NYSE:AGM), Denali Therapeutics (NASDAQ:DNLI), ResMed (NYSE:RMD), Actinium Pharma (AMEX:ATNM), Southwest Airlines (NYSE:LUV), IQVIA Hldgs (NYSE:IQV), Semtech (NASDAQ:SMTC), Stem (NYSE:STEM), Intapp (NASDAQ:INTA), Lucid Gr (NASDAQ:LCID), Plains All American (NASDAQ:PAA), First Solar (NASDAQ:FSLR), Cenovus Energy (NYSE:CVE), Procaps Gr (NASDAQ:PROC), Silk Road Medical (NASDAQ:SILK), AeroVironment (NASDAQ:AVAV), Enbridge (NYSE:ENB), Penumbra (NYSE:PEN), Kinetik Holdings (NYSE:KNTK), Allegion (NYSE:ALLE), Gilead Sciences (NASDAQ:GILD), Toast (NYSE:TOST), Laboratory Corp (NYSE:LH), Adecoagro (NYSE:AGRO), Biogen (NASDAQ:BIIB), Bitdeer Technologies (NASDAQ:BTDR), Plains GP Holdings (NASDAQ:PAGP), Prime Medicine (NASDAQ:PRME)
Source: benzinga.com
